- Home
- ALEC vs PRE Comparison
ALEC vs PRE Comparison
Compare ALEC & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- PRE
- Stock Information
- Founded
- ALEC 2013
- PRE 2014
- Country
- ALEC United States
- PRE Hong Kong
- Employees
- ALEC N/A
- PRE N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- ALEC Health Care
- PRE Industrials
- Exchange
- ALEC Nasdaq
- PRE Nasdaq
- Market Cap
- ALEC 124.0M
- PRE 105.1M
- IPO Year
- ALEC 2019
- PRE N/A
- Fundamental
- Price
- ALEC $1.60
- PRE $8.05
- Analyst Decision
- ALEC Buy
- PRE Buy
- Analyst Count
- ALEC 8
- PRE 1
- Target Price
- ALEC $4.50
- PRE $9.00
- AVG Volume (30 Days)
- ALEC 415.3K
- PRE 45.7K
- Earning Date
- ALEC 08-11-2025
- PRE 08-05-2025
- Dividend Yield
- ALEC N/A
- PRE N/A
- EPS Growth
- ALEC N/A
- PRE N/A
- EPS
- ALEC N/A
- PRE N/A
- Revenue
- ALEC $88,339,000.00
- PRE $41,520,000.00
- Revenue This Year
- ALEC N/A
- PRE $198.17
- Revenue Next Year
- ALEC $319.82
- PRE $59.73
- P/E Ratio
- ALEC N/A
- PRE N/A
- Revenue Growth
- ALEC N/A
- PRE 78.72
- 52 Week Low
- ALEC $0.87
- PRE $3.10
- 52 Week High
- ALEC $6.52
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- ALEC 49.80
- PRE 49.64
- Support Level
- ALEC $1.74
- PRE $7.78
- Resistance Level
- ALEC $2.00
- PRE $8.80
- Average True Range (ATR)
- ALEC 0.12
- PRE 0.39
- MACD
- ALEC -0.01
- PRE -0.03
- Stochastic Oscillator
- ALEC 14.93
- PRE 35.46
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.